You're offline - Playing from downloaded podcasts
Back to All Episodes
Podcast Episode

Anthropic's Claude Fable 5 Draws Fire for Blocking Basic Biology Questions

June 11, 2026

0:00
5:37
Podcast Thumbnail

Anthropic launched Claude Fable 5, its first publicly available Mythos-class model, but its automated safety classifiers are blocking routine questions about biology, medicine, and cybersecurity. Users report refusals on everything from asthma medication to board presentations, with some accounts rerouted to the older Opus 4.8 model entirely.

A Powerful Model That Won't Talk Science

Anthropic launched Claude Fable 5 on Tuesday, its first publicly available Mythos-class AI model, only to face immediate backlash. Within hours, users reported that the system's automated safety classifiers were blocking routine questions about biology, medicine, and cybersecurity — the very topics the model was marketed as excelling in. The result is the strange spectacle of one of the most advanced models ever released to the public refusing to explain how an asthma inhaler works.

Broad Filters, Narrow Access

Fable 5 shares its underlying architecture with Claude Mythos 5, a restricted model available only to vetted partners. The key difference is a layer of classifiers that monitor requests involving cybersecurity, biology, chemistry, and model distillation. When triggered, responses are silently routed to Claude Opus 4.8, Anthropic's previous top model. Anthropic says the fallback fires in fewer than 5 percent of sessions on average.

That average obscures a sharper problem. The Verge reported that Fable refused to answer basic biology questions a high school student could handle, including queries about hay fever, antibiotic resistance, and how asthma medication works. On Reddit, a cancer researcher said that because their account profile mentions terms like "prostate cancer cell lines," every single query — including greetings and weather questions — gets rerouted to Opus 4.8. Anthropic spokesperson Paruul Maheshwary told The Verge the company "made this trade so customers benefit from the model's capabilities sooner without the risks."

Industry Reaction

The restrictions have drawn criticism from analysts and early users. Patrick Moorhead, CEO of Moor Insights & Strategy, wrote on X that Fable 5 refused to help with earnings-analysis talking points and a board presentation because it deemed the tasks "too dangerous." "Is this the model we're all frightened of and makes Anthropic worth $1T?" he wrote. Meanwhile, Microsoft is reportedly restricting employee use of Fable 5 over concerns about Anthropic's mandatory 30-day data retention policy for all Mythos-class model traffic.

A Deliberate Trade-Off

Anthropic has been transparent that the biology filters are intentionally conservative. The company said Fable 5 is the first Mythos-class model it believes has "the ability for bad actors to use for highly risky biological research," and that an overly cautious approach was necessary for safe deployment. The company says it is working to reduce false positives and plans to extend unrestricted Mythos 5 access to broader life sciences researchers through a trusted access programme. Through 22nd June, Fable 5 remains included at no extra cost for Pro, Max, Team, and Enterprise subscribers, after which access will require usage credits. The controversy lands amid reports that Anthropic is heading towards a potentially record-breaking IPO.

Published June 11, 2026 at 2:43am

More Recent Episodes